Q3 sales rose by +12% (+17% in LC) to €730m, of which 8pp attributable to portfolio changes (Pinova acquisition). The gross profit margin declined from 42.9% to 39.8% burdened by the acquisition. EBITDA was slightly up (+1% to €150m), whereas net income attributable to shareholders declined by -9% to €60m. 9M operating CF came in -13% lower at €218m suffering from various factors despite higher D/A. Changes in other non-current assets swung into the red and NWC outflow wen
02 Nov 2016
Scent&Care with additional burden
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Scent&Care with additional burden
Symrise AG (SY1:WBO) | 0 0 1.0% | Mkt Cap: 8,612m
- Published:
02 Nov 2016 -
Author:
Martin Schnee -
Pages:
3
Q3 sales rose by +12% (+17% in LC) to €730m, of which 8pp attributable to portfolio changes (Pinova acquisition). The gross profit margin declined from 42.9% to 39.8% burdened by the acquisition. EBITDA was slightly up (+1% to €150m), whereas net income attributable to shareholders declined by -9% to €60m. 9M operating CF came in -13% lower at €218m suffering from various factors despite higher D/A. Changes in other non-current assets swung into the red and NWC outflow wen